Suven Life Sciences [SUVEN] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Suven Life Sciences Ltd.

NSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Suven Life Sciences Ltd. wins in 3 metrics, Divi's Laboratories Ltd. wins in 14 metrics, with 1 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Suven Life Sciences Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) -27.46 67.11 Divi's Laboratories Ltd.
Price-to-Book Ratio 16.79 10.82 Divi's Laboratories Ltd.
Debt-to-Equity Ratio 0.00 0.58 Tie
PEG Ratio -0.18 4.63 Divi's Laboratories Ltd.
EV/EBITDA -16.05 48.63 Divi's Laboratories Ltd.
Profit Margin (TTM) 84.44% 24.04% Suven Life Sciences Ltd.
Operating Margin (TTM) -3,727.57% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) N/A 29.65% N/A
Return on Equity -146.15% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) -118.91% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-1.91B $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return 13.65% -0.43% Suven Life Sciences Ltd.
Price-to-Sales Ratio (TTM) 794.04 16.18 Divi's Laboratories Ltd.
Enterprise Value $44.58B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 631.27 15.86 Divi's Laboratories Ltd.
Gross Profit Margin (TTM) 100.00% 63.71% Suven Life Sciences Ltd.
Revenue per Share (TTM) $0 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $-12.31 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.30 0.19 Divi's Laboratories Ltd.

Suven Life Sciences Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

SUVEN
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Suven Life Sciences Ltd.0.60%15.54%27.80%96.81%52.40%63.85%
Divi's Laboratories Ltd.-0.44%1.34%-2.25%8.85%4.11%4.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Suven Life Sciences Ltd.13.65%309.23%215.11%2,691.36%26,459.41%157,694.12%
Divi's Laboratories Ltd.-0.43%85.44%58.15%496.33%1,610.60%10,946.76%

Performance & Financial Health Analysis: Suven Life Sciences Ltd. vs Divi's Laboratories Ltd.

MetricSUVENDIVISLAB
Market Information
Market Cap i₹53.28B₹1.69T
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i733,679253,443
90 Day Avg. Volume i644,024283,911
Last Close₹269.85₹6,608.50
52 Week Range₹124.11 - ₹299.99₹5,636.50 - ₹7,071.50
% from 52W High-10.05%-6.55%
All-Time High₹338.50 (Apr 13, 2015)₹7,071.50 (Jul 08, 2025)
% from All-Time High-20.28%-6.55%
Growth Metrics
Quarterly Revenue Growth0.75%0.12%
Quarterly Earnings Growth0.74%-0.01%
Financial Health
Profit Margin (TTM) i0.84%0.24%
Operating Margin (TTM) i-37.28%0.30%
Return on Equity (TTM) i-1.46%0.15%
Debt to Equity (MRQ) i0.000.58
Cash & Liquidity
Book Value per Share (MRQ)₹12.66₹580.95
Cash per Share (MRQ)₹11.50₹122.95
Operating Cash Flow (TTM) i₹-1,590,282,000₹19.67B
Levered Free Cash Flow (TTM) i₹-1,607,450,000₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend i₹0.00₹60.00

Valuation & Enterprise Metrics Analysis: Suven Life Sciences Ltd. vs Divi's Laboratories Ltd.

MetricSUVEN (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-27.4667.11
Forward P/E i10.9953.75
PEG Ratio i-0.184.63
Price to Sales (TTM) i794.0416.18
Price to Book (MRQ) i16.7910.82
Market Capitalization
Market Capitalization i₹53.28B₹1.69T
Enterprise Value i₹44.58B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i631.2715.86
Enterprise to EBITDA i-16.0548.63
Risk & Other Metrics
Beta i0.300.19
Book Value per Share (MRQ) i₹12.66₹580.95

Financial Statements Comparison: Suven Life Sciences Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSUVEN (2025)DIVISLAB (2025)
Revenue/Sales i66.56M93.25B
Cost of Goods Sold i10.36M38.70B
COGS % of Revenue i15.6%41.5%
Gross Profit i56.20M54.55B
Gross Margin i84.4%58.5%
Research & Development i1.44B270.00M
Operating Income (EBIT) i-1.71B25.71B
Operating Margin i-2,572.9%27.6%
EBITDA i-1.60B33.19B
EBITDA Margin i-2,401.7%35.6%
Pre-Tax Income i-1.61B29.16B
Pre-Tax Income % of Revenue i-2,415.1%31.3%
Income Tax i07.25B
Income Tax % of Revenue i0.0%7.8%
Net Income (Profit) i-1.61B21.91B
Profit Margin i-2,415.1%23.5%

Balance Sheet & Liquidity Metrics

MetricSUVEN (2025)DIVISLAB (2025)
Cash & Equivalents i150.26M4.15B
Total Current Assets i754.72M100.81B
Total Current Assets % of Revenue i1,133.9%108.1%
Total Current Liabilities i234.86M14.52B
Total Current Liabilities % of Revenue i352.9%15.6%
Long-Term Debt iN/A20.00M
Long-Term Debt % of Revenue i0.0%0.0%
Total Shareholders Equity i1.10B149.69B
Retained Earnings i-6.01B134.00B
Retained Earnings % of Revenue i-9,024.8%143.7%
Property, Plant & Equipment i756.69M3.19B

Cash Flow Statement Comparison

MetricSUVEN (2025)DIVISLAB (2025)
Operating Cash Flow i-1.59B19.67B
Operating Cash Flow % of Revenue i-2,389.3%21.1%
Capital Expenditures i-372.76M-14.38B
Free Cash Flow i-1.91B2.15B
FCF Margin i-2,875.4%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSUVENDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i263.72M265.47M
Float Shares i63.70M117.72M
% Held by Insiders i71.40%52.04%
% Held by Institutions i3.09%28.65%
% Held by Public i25.51%19.31%

Dividend Analysis & Yield Comparison: Suven Life Sciences Ltd. vs Divi's Laboratories Ltd.

MetricSUVENDIVISLAB
Last 12-Month Dividend i₹0.00₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend i₹0.00₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends i₹0.00₹150.00
Ex-Dividend DateN/AJul 25, 2025